OR WAIT null SECS
August 26, 2020
The contract is valued at $106.3 million and is supported by Operation Warp Speed.
Medical management services provider, Europital, has announced the opening of a new site in Oxford, United Kingdom, in response to demand from small and medium innovators within the biotech industry.
Mapp has selected Avid to provide process transfer, scale-up, and clinical manufacturing services for one of its development programs for a novel antiviral drug candidate.
Müller + Müller will become part of DWK upon closing in September 2020 and will continue to function under the same name and management.
August 24, 2020
Catalent will manufacture drug substance for AZD1222 at its Harmans, MD facility.
August 21, 2020
CDMO Avid Bioservices will provide development and drug substance manufacturing for Oragenics’ novel COVID-19 vaccine candidate, Terra CoV-2.
August 20, 2020
Avacta Group has expanded its drug development partnership with LG Chem Life Sciences to include new programs incorporating Avacta’s Affimer XT technology.
CARBOGEN AMCIS has announced significant investments to increase manufacturing capacity in Switzerland and France.
Bristol Myers Squibb will handle the development and commercialization of DF6002 and its related products worldwide, including strategic decisions, regulatory responsibilities, funding, and manufacturing.
The collaboration will increase the supply of the potential treatment to at least three and a half times the current capacity.